Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated...

PLoS ONE 2015 / 4 Vol. 10; Iss. 4

Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study

Ohta, Ken, Ichinose, Masakazu, Tohda, Yuji, Engel, Michael, Moroni-Zentgraf, Petra, Kunimitsu, Satoko, Sakamoto, Wataru, Adachi, Mitsuru, Arjomandi, Mehrdad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0124109
Date:
April, 2015
File:
PDF, 431 KB
english, 2015
Conversion to is in progress
Conversion to is failed